Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exair® Prolapse Repair System Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Exair 522 Study

NCT02162628 is registered in ClinicalTrials.gov with Coloplast A/S as lead sponsor.

NCT NCT02162628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02162628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exair® Prolapse Repair System Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Exair 522 Study
Lead sponsor
Coloplast A/S
Phase
Observational
Overall status
Terminated
Start date
August 31, 2014
Completion date
December 31, 2015
Enrollment
79 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

pelvic organ prolapse